In this free webinar, learn about clear and comprehensive device development road mapping, including risk factors that may stall combination product developments. Hear from expert speakers about mitigation strategies to address risks as they arise and streamline development.
TORONTO, Sept. 5, 2023 /PRNewswire-PRWeb/ -- The global combination products market has seen a tremendous amount of growth driven primarily by the rise in new therapies to address chronic diseases. Additionally, the demand for self-administered therapies is pushing the need for new, intuitive, user-driven delivery devices. Novel technologies are also contributing to this growth by offering opportunities to improve drug uptake, reduce pain and improve patient compliance.
As pharmaceutical companies advance new therapies to market, their focus is primarily on the drug or biologic. However, consideration of the delivery device and the drug-device combination is essential for patient safety and regulatory approval. Without the proper foresight and planning, significant challenges on the device side arise, including complexities related to reliability, human factors, performance testing and process validations.
These challenges are often compounded by accelerated schedules after therapeutic efficacy has been demonstrated during Phase I and Phase II clinical trials. At these inflection points, there is significant commercial motivation to accelerate schedules for combination products for Phase III trials and commercial launch. Unfortunately, many combination product development teams place too little emphasis on the device constituent part. This often results in prolonged device development activities and redo loops that significantly delay commercial milestones.
This webinar will help developers of combination products clearly understand the device development process. The goal is for participants to understand the risk factors that may arise and put in place mitigation strategies that will streamline the device development process. Register now to learn how to develop a clear and comprehensive plan to succeed in combination product development.
Register for the live webinar taking place on Wednesday, September 27, 2023, at 11am EDT (4pm BST/UK) featuring industry experts Eric Sugalski, President and CEO, Archimedic; and Jen Riter, Senior Director, Business and Technical Operations, West Pharmaceutical Services, Inc.
For more information, or to register for this event, visit Combination Products: Critical Steps to Successfully Accelerate Time-to-Market.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Media Contact
Ayesha Rashid, Xtalks, +1 (416) 977-6555 x272, arashid@xtalks.com
SOURCE Xtalks
